McGrath J A, Ashton G H, Mellerio J E, Salas-Alanis J C, Swensson O, McMillan J R, Eady R A
Department of Cell and Molecular Pathology, St John's Institute of Dermatology, The Guy's, King's College and St Thomas' Hospitals' Medical School, St Thomas' Hospital, London, UK.
J Invest Dermatol. 1999 Sep;113(3):314-21. doi: 10.1046/j.1523-1747.1999.00709.x.
Non-sense mutations on both alleles of either the type VII collagen gene (COL7A1) or the genes encoding laminin 5 (LAMA3, LAMB3, or LAMC2) usually result in clinically severe forms of recessive dystrophic or junctional epidermolysis bullosa, respectively. In this study we assessed two unrelated families whose mutations in genomic DNA predicted severe recessive dystrophic epidermolysis bullosa or junctional epidermolysis bullosa phenotypes but in whom the manifestations were milder than expected. The recessive dystrophic epidermolysis bullosa patients had a homozygous single base-pair frameshift mutation in exon 19 of COL7A1 (2470insG). Clinically, there was generalized blistering but only mild scarring. Skin biopsy revealed positive type VII collagen immunoreactivity and recognizable anchoring fibrils. The junctional epidermolysis bullosa patients were compound heterozygotes for a frameshift/non-sense combination of mutations in exons 3 and 17 of LAMB3 (29insC/Q834X). These patients did not have the lethal form of junctional epidermolysis bullosa but, as adults, displayed the milder generalized atrophic benign epidermolysis bullosa variant. There was undetectable laminin 5 staining at the dermal-epidermal junction using an antibody to the beta3 chain, but faintly positive alpha3 and gamma2 chain labeling, and there was variable hypoplasia of hemidesmosomes. To explain the milder recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa phenotypes in these families, reverse transcription-polymerase chain reaction, using RNA extracted from frozen skin, was able to provide evidence for some rescue of mutant mRNA transcripts with restoration of the open- reading frame. In the recessive dystrophic epidermolysis bullosa patients, transcripts containing in-frame skipping of exon 19 of COL7A1 in the cDNA were detected, and in the junctional epidermolysis bullosa patients transcripts with in-frame skipping of exon 17 of LAMB3 were identified. The truncated proteins encoded by these transcripts are expected to lack certain critical domains involved in cell-matrix attachment, but may still be able to contribute to adhesion thereby moderating the severity of the skin blistering. This study shows the limitations in predicting phenotype in epidermolysis bullosa solely based on mutation analysis of genomic DNA and emphasizes the importance of immunohistochemistry, electron microscopy, and mRNA assessment as parallel investigations.
VII型胶原蛋白基因(COL7A1)或编码层粘连蛋白5的基因(LAMA3、LAMB3或LAMC2)的两个等位基因上的无义突变通常分别导致临床上严重形式的隐性营养不良型或交界型大疱性表皮松解症。在本研究中,我们评估了两个无亲缘关系的家系,其基因组DNA中的突变预测为严重的隐性营养不良型大疱性表皮松解症或交界型大疱性表皮松解症表型,但临床表现比预期的要轻。隐性营养不良型大疱性表皮松解症患者在COL7A1基因第19外显子上有一个纯合的单碱基对移码突变(2470insG)。临床上,有全身性水疱形成,但仅有轻度瘢痕形成。皮肤活检显示VII型胶原蛋白免疫反应阳性且有可识别的锚定纤维。交界型大疱性表皮松解症患者是LAMB3基因第3和17外显子突变(29insC/Q834X)的移码/无义组合的复合杂合子。这些患者没有交界型大疱性表皮松解症的致死形式,而是成年后表现出较轻的全身性萎缩性良性大疱性表皮松解症变异型。使用针对β3链的抗体在真皮-表皮交界处未检测到层粘连蛋白5染色,但α3和γ2链标记呈弱阳性,且半桥粒有不同程度的发育不全。为了解释这些家系中较轻的隐性营养不良型大疱性表皮松解症和交界型大疱性表皮松解症表型,利用从冷冻皮肤中提取的RNA进行逆转录-聚合酶链反应,能够为一些突变mRNA转录本的挽救以及开放阅读框的恢复提供证据。在隐性营养不良型大疱性表皮松解症患者中,检测到cDNA中含有COL7A1基因第19外显子框内跳跃的转录本,在交界型大疱性表皮松解症患者中鉴定出含有LAMB3基因第17外显子框内跳跃的转录本。预计这些转录本编码的截短蛋白缺乏参与细胞-基质附着的某些关键结构域,但仍可能有助于黏附,从而减轻皮肤水疱形成的严重程度。本研究显示了仅基于基因组DNA突变分析预测大疱性表皮松解症表型的局限性,并强调了免疫组织化学、电子显微镜检查和mRNA评估作为平行研究的重要性。